Tenax Therapeutics, Inc.

Tradey thinks it is not wise to invest in Tenax Therapeutics, Inc..
Log in to see more information.
Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing, and...

News

Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com

Ticker Report StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Free Report) in a research note published on Tuesday morning. The brokerage issued a sell rating on the specialty...\n more…

Tenax Therapeutics (NASDAQ:TENX) Share Price Passes Above 200 Day Moving Average of $3.67
Tenax Therapeutics (NASDAQ:TENX) Share Price Passes Above 200 Day Moving Average of $3.67

Zolmax Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of...\n more…

Tenax Therapeutics (NASDAQ:TENX) Research Coverage Started at StockNews.com
Tenax Therapeutics (NASDAQ:TENX) Research Coverage Started at StockNews.com

Zolmax Equities researchers at StockNews.com began coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a "sell...\n more…

Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com

Zolmax StockNews.com began coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Free Report) in a research note issued to investors on Monday. The firm issued a sell rating on the specialty...\n more…

Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com
Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com

Ticker Report StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Free Report) in a report published on Monday. The firm issued a sell rating on the specialty pharmaceutical company's...\n more…

Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com
Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com

Ticker Report Analysts at StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX - Get Free Report) in a research note issued on Sunday. The brokerage set a "sell" rating on the specialty...\n more…